Toxicological Assays
Identifying potential toxicity at early research stages allows to optimize new compounds development.
Cell-based in vitro models are a recommended option to understand xenobiotic’s toxicological profile. ReadyCell offers innovative ready-to-use biotechnology indicated for early safety assessment.
Predictive intestinal in vitro acute toxicity
24 or 96 multiwell insert plates seeded with 21 days differentiated and polarized Caco-2 cells. Expose your development molecules to a confluent monolayer and determine cytotoxicity and cellular viability.
More info...
REFERENCE DESCRIPTION
KRECE-CCT01 CacoTox 24 MultiWell
KRECE-CCT50 CacoTox 96 MultiWell
ReadyCell ready-to-use cell monolayer kits benefits
- No in-house cell culture maintenance nor cell licensing costs
- Shipments worldwide to any location at room temperature thanks to our patented technology
- High flexibility
- High reproducibility within and between manufacturing batches
- Cell-based assays ready-to-use
- Full cell functionality after transportation
- Highly predictive and useful in the in vitro to in vivo progression
- Validation data available and high quality-control standards
- Technical support during the assay and in bio-analytics
Related News
Assessment of Drug Permeation across the Blood-Brain-Barrier (BBB) in preclinical research
The endothelial cells that conform the BBB limit the passage of blood circulating endogenous substrates and larger molecules to the brain. This intrinsic protective role is also a major hurdle for reasearchers developing drugs for Central Nervous System (CNS) disorders.
CacoReady in the literature
Evaluate intestinal inflammation with Caco2 cell-based in vitro kits to reproduce phisiological conditions.
Review of available cell-based in vitro models to evaluate intestinal permeability
Cell-based in vitro models are suitable to evaluate human phisiology optimizing research. This review introduce reference models to evaluate gastrointestinal metabolism.